tiprankstipranks
Trending News
More News >
AbbVie (ABBV)
NYSE:ABBV
US Market

AbbVie (ABBV) Technical Analysis

Compare
22,494 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
6Neutral
10Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
AbbVie’s (ABBV) Moving Averages Convergence Divergence (MACD) indicator is 0.22, suggesting AbbVie is a Sell.
AbbVie’s (ABBV) 20-Day exponential moving average is 188.38, while AbbVie’s (ABBV) share price is $188.09, making it a Sell.
AbbVie’s (ABBV) 50-Day exponential moving average is 190.02, while AbbVie’s (ABBV) share price is $188.09, making it a Sell.

AbbVie (ABBV) Pivot Points

May 08, 2025, 01:51 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
173.24
179.49
183.32
189.57
193.40
199.65
203.48
Fibonacci
179.49
183.34
185.72
189.57
193.42
195.80
199.65
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (ABBV) Moving Averages

May 08, 2025, 01:51 PM
Period
Simple
Exponential
MA5
192.62Sell
190.66Sell
MA10
191.05Sell
189.51Sell
MA20
182.73Buy
188.38Sell
MA50
195.81Sell
190.02Sell
MA100
187.63Buy
188.49Sell
MA200
186.06Buy
183.97Buy
AbbVie’s (ABBV) 10-Day exponential moving average is 189.51, while AbbVie’s (ABBV) share price is $188.09, making it a Sell.
AbbVie’s (ABBV) 100-Day exponential moving average is 188.49, while AbbVie’s (ABBV) share price is $188.09, making it a Sell.
AbbVie’s (ABBV) stock price is $188.09 and AbbVie’s (ABBV) 50-day simple moving average is 195.81, creating a Sell signal.
AbbVie’s (ABBV) stock price is $188.09 and AbbVie’s (ABBV) 100-day simple moving average is 187.63, creating a Buy signal.
AbbVie’s (ABBV) stock price is $188.09 and AbbVie’s (ABBV) 200-day simple moving average is 186.06, creating a Buy signal.

AbbVie (ABBV) Technical Indicators

May 08, 2025, 01:51 PM
Name
Value
Implied Action
RSI (14)
49.17
Neutral
STOCH (9,6)
59.70
Neutral
STOCHRSI (14)
71.93
Neutral
MACD (12,26)
0.22
Sell
ADX (14)
24.11
Neutral
Williams %R
-35.78
Buy
CCI (14)
45.69
Neutral
ATR (14)
6.43
-
Ultimate Oscillator
52.11
Neutral
ROC
9.56
Buy
AbbVie’s (ABBV) Relative Strength Index (RSI) is 49.17, creating a Neutral signal.
AbbVie’s (ABBV) Trend Strength Indicator (ADX) is 24.11, creating a Neutral signal.
AbbVie’s (ABBV) Commodity Channel Index (CCI) is 45.69, creating a Neutral signal.
AbbVie’s (ABBV) Price Rate of Change (ROC) is 9.56, creating a Buy signal.

FAQ

Is ABBV a Buy, Hold, or Sell?
Based on ABBV’s technical indicators, ABBV is a Sell.
    What is ABBV’s RSI (14)?
    ABBV’s RSI (14) is 49.17, which suggests ABBV is a Neutral.
      What is ABBV’s MACD?
      ABBV’s MACD is 0.22, which suggests ABBV is a Sell.
        What is ABBV’s 5-day moving average?
        ABBV’s 5-day moving average is 192.62, which suggests ABBV is a Sell.
          What is ABBV’s 20-day moving average?
          ABBV 20-day moving average is 182.73, which suggests ABBV is a Buy.
            What is ABBV’s 50-day moving average?
            ABBV’s 50-day moving average is 195.81, which suggests ABBV is a Sell.
              What is ABBV’s 200-day moving average?
              ABBV’s 200-day moving average is 186.06, which suggests ABBV is a Buy.
                What is ABBV’s Williams % R (14)?
                ABBV’s Williams % R (14) is -35.78, which suggests ABBV is a Buy.
                  What is ABBV’s CCI (14)?
                  ABBV’s CCI (14) is 45.69, which suggests ABBV is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis